Adjusted EBITDA flipped from a loss to a $2.9 million profit.
Repurchased $23.5 million in stock and authorized another $70 million.
GAAP operating loss of $5.8 million persists despite revenue growth.
Ongoing litigation with potential liability up to $24.1 million.
The Q1 2026 filing reveals a company in a tug-of-war between accelerating transaction velocity and persistent operational losses. On one hand, the growth in financing fees and the shift toward positive Adjusted EBITDA suggest that the market is repricing and MMI is well-positioned to capture that momentum. The aggressive share repurchase program indicates management's confidence in the intrinsic value of the firm and its ability to navigate a high-interest-rate environment. However, the disconnect between non-GAAP metrics and GAAP operating losses highlights a fragile recovery. Investors must weigh the excitement of top-line growth and capital returns against the reality of negative operating cash flows and significant contingent liabilities. The ultimate trajectory of the stock will likely depend on whether the current surge in transaction volume can translate into sustainable GAAP profitability and whether the company can manage its guarantee exposures without depleting its cash reserves.